Company profile ORMP
After 38 days of this quarter the interest is at 30.0. Based on that we can calculate that during remaining 53 days it will total up to 72.0. oramed pharmaceuticals -stock expected interest is significantly lower compared to same quarter last year (-68.7%) but similar to previous quarter.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 59 | 114 93.2% QoQ | 103 -9.6% QoQ | 73 -29.1% QoQ |
| 2020 | 151 155.9% YoY 106.8% QoQ | 24 -78.9% YoY -84.1% QoQ | 181 75.7% YoY 654.2% QoQ | 118 61.6% YoY -34.8% QoQ |
| 2021 | 67 -55.6% YoY -43.2% QoQ | 190 691.7% YoY 183.6% QoQ | 238 31.5% YoY 25.3% QoQ | 356 201.7% YoY 49.6% QoQ |
| 2022 | 129 92.5% YoY -63.8% QoQ | 94 -50.5% YoY -27.1% QoQ | 132 -44.5% YoY 40.4% QoQ | 247 -30.6% YoY 87.1% QoQ |
| 2023 | 230 78.3% YoY -6.9% QoQ | 106 12.8% YoY -53.9% QoQ | 207 56.8% YoY 95.3% QoQ | 81 -67.2% YoY -60.9% QoQ |
| 2024 | 30 -87.0% YoY -63.0% QoQ | - | - | - |
The average 5 years interest of oramed pharmaceuticals -stock was 11.27 per week. The last year interest of oramed pharmaceuticals -stock compared to the last 5 years has changed by -17.21%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 29.05%.
After 38 days of this quarter the interest is at 0.0. Based on that we can calculate that during remaining 53 days it will total up to 0.0. oramed stock price expected interest is significantly lower compared to previous quarter (-100.0%) and same quarter last year (-100.0%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 24 | 81 237.5% QoQ | 68 -16.0% QoQ | 91 33.8% QoQ |
| 2020 | 22 -8.3% YoY -75.8% QoQ | 77 -4.9% YoY 250.0% QoQ | 86 26.5% YoY 11.7% QoQ | 63 -30.8% YoY -26.7% QoQ |
| 2021 | 242 1000.0% YoY 284.1% QoQ | 260 237.7% YoY 7.4% QoQ | 254 195.3% YoY -2.3% QoQ | 309 390.5% YoY 21.7% QoQ |
| 2022 | 110 -54.5% YoY -64.4% QoQ | 125 -51.9% YoY 13.6% QoQ | 175 -31.1% YoY 40.0% QoQ | 50 -83.8% YoY -71.4% QoQ |
| 2023 | 167 51.8% YoY 234.0% QoQ | 215 72.0% YoY 28.7% QoQ | 192 9.7% YoY -10.7% QoQ | 44 -12.0% YoY -77.1% QoQ |
| 2024 | 0 -100.0% YoY -100.0% QoQ | - | - | - |
The average 5 years interest of oramed stock price was 10.21 per week. The last year interest of oramed stock price compared to the last 5 years has changed by 12.63%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 109.09%.
There is not enough data for oramed insulin capsule to provide analysis
There is not enough data for oramed insulin capsule to provide correlation calculation
There is not enough data for oramed insulin capsule to provide analysis
There is not enough data for oramed diabetes treatment to provide analysis
There is not enough data for oramed diabetes treatment to provide correlation calculation
There is not enough data for oramed diabetes treatment to provide analysis
There is not enough data for oramed oral insulin to provide analysis
There is not enough data for oramed oral insulin to provide correlation calculation
There is not enough data for oramed oral insulin to provide analysis
There is not enough data for oramed clinical trials to provide analysis
There is not enough data for oramed clinical trials to provide correlation calculation
There is not enough data for oramed clinical trials to provide analysis
There is not enough data for oramed pharmaceutical solutions to provide analysis
There is not enough data for oramed pharmaceutical solutions to provide correlation calculation
There is not enough data for oramed pharmaceutical solutions to provide analysis
There is not enough data for oramed glucagon-like peptide-1 to provide analysis
There is not enough data for oramed glucagon-like peptide-1 to provide correlation calculation
There is not enough data for oramed glucagon-like peptide-1 to provide analysis
There is not enough data for oramed non-alcoholic steatohepatitis to provide analysis
There is not enough data for oramed non-alcoholic steatohepatitis to provide correlation calculation
There is not enough data for oramed non-alcoholic steatohepatitis to provide analysis
There is not enough data for oramed research and development to provide analysis
There is not enough data for oramed research and development to provide correlation calculation
There is not enough data for oramed research and development to provide analysis